Joshua D Wallach

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 20

Top Venues

BMJ medicine

Clinical trials (London, England)

BMC medicine

BMJ open

Yale School of Public Health

Stanford University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yale School of Public Health Sep 1o 2018

United States

Assistant Professor :: Environmental Health Sciences

Education History

Stanford University School of Medicine Jan 6o 2014

United States

PHD :: Health Research and Policy

Publications

Joshua D Wallach, Yihong Deng, Eric C Polley, Sanket S Dhruva, Jeph Herrin, Kenneth Quinto, Charu Gandotra, William Crown, Peter Noseworthy, Xiaoxi Yao, Molly Moore Jeffery, Timothy D Lyon, Joseph R Ross, Rozalina G McCoy
Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trials. Clinical trials (London, England) (2023)
Yihong Deng, Eric C Polley, Joshua D Wallach, Jeph Herrin, Joseph R Ross, Rozalina Grubina McCoy
Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial. BMJ medicine 2 (1) (2023)
Osman Moneer, Garrison Daly, Joshua J Skydel, Kate Nyhan, Peter Lurie, Joseph S Ross, Joshua D Wallach
Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study. BMJ (Clinical research ed.) 377 (2022)
Xiaoting Shi, Haoran Zhuo, Yuxuan Du, Kate Nyhan, John P A Ioannidis, Joshua D Wallach
Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data. BMJ medicine 1 (1) (2022)
Xiaoting Shi, Haoran Zhuo, Yuxuan Du, Kate Nyhan, John P A Ioannidis, Joshua D Wallach
Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data. BMJ medicine 1 (1) (2022)
Henri Gouraud, Joshua D Wallach, Rémy Boussageon, Joseph R Ross, Florian Naudet
Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis. BMJ medicine 1 (1) (2022)
Joshua D Wallach, Ralitza Gueorguieva, Huong Phan, Katie A Witkiewitz, Ran Wu, Stephanie S O'Malley
Predictors of abstinence, no heavy drinking days, and a 2-level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study. Alcoholism, clinical and experimental research 46 (7) (2022)
Henri Gouraud, Joshua D Wallach, Rémy Boussageon, Joseph R Ross, Florian Naudet
Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis. BMJ medicine 1 (1) (2022)
Enrique Vazquez, Henri Gouraud, Florian Naudet, Cary P Gross, Harlan M Krumholz, Joseph R Ross, Joshua D Wallach
Characteristics of available studies and dissemination of research using major clinical data sharing platforms. Clinical trials (London, England) 18 (6) (2021)
Joshua D Wallach, Taeho Greg Rhee, E Jennifer Edelman, Nilay D Shah, Stephanie S O'Malley, Joseph S Ross
U.S. Prescribing of On-and-Off-Label Medications for Alcohol Use Disorder in Outpatient Visits: NAMCS 2014 to 2016. Journal of general internal medicine (2021)
Joshua J Skydel, Audrey D Zhang, Sanket S Dhruva, Joseph R Ross, Joshua D Wallach
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018. Clinical trials (London, England) 18 (4) (2021)
Stylianos Serghiou, Despina G Contopoulos-Ioannidis, Kevin W Boyack, Nico Riedel, Joshua D Wallach, John P A Ioannidis
Assessment of transparency indicators across the biomedical literature: How open is open? PLoS biology 19 (3) (2021)
Mallory K Ellingson, Xiaoting Shi, Joshua J Skydel, Kate Nyhan, Richard Lehman, Joseph S Ross, Joshua D Wallach
Publishing at any cost: a cross-sectional study of the amount that medical researchers spend on open access publishing each year. BMJ open 11 (2) (2021)
Joshua D Wallach, Stylianos Serghiou, Lingzhi Chu, Alexander C Egilman, Vasilis Vasiliou, Joseph S Ross, John P A Ioannidis
Evaluation of confounding in epidemiologic studies assessing alcohol consumption on the risk of ischemic heart disease. BMC medical research methodology 20 (1) (2020)
Joshua D Wallach, Kun Wang, Audrey D Zhang, Deanna Cheng, Holly K Grossetta Nardini, Haiqun Lin, Michael B Bracken, Mayur Desai, Harlan M Krumholz, Joseph S Ross
Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses. BMJ (Clinical research ed.) 368 (2020)
Joshua D Wallach, Anita T Luxkaranayagam, Sanket S Dhruva, Jennifer E Miller, Joseph S Ross
Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis. BMC medicine 17 (1) (2019)
Patrick Liu, John P A Ioannidis, Joseph S Ross, Sanket S Dhruva, Anita T Luxkaranayagam, Vasilis Vasiliou, Joshua D Wallach
Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study. BMC medicine 17 (1) (2019)
Patrick Liu, Joseph S Ross, John Pa Ioannidis, Sanket S Dhruva, Vasilis Vasiliou, Joshua D Wallach
Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews. Clinical trials (London, England) 17 (2) (2019)
Cynthia A Jackevicius, JaeJin An, Dennis T Ko, Joseph S Ross, Suveen Angraal, Joshua D Wallach, Maria Koh, Jeeeun Song, Harlan M Krumholz
Submissions from the SPRINT Data Analysis Challenge on clinical risk prediction: a cross-sectional evaluation. BMJ open 9 (3) (2019)
Joshua D Wallach, Oriana Ciani, Alison M Pease, Gregg S Gonsalves, Harlan M Krumholz, Rod S Taylor, Joseph S Ross
Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study. BMC medicine 16 (1) (2018)

Joshua D Wallach.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joshua D Wallach